Proteus syndrome: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
|||
Line 91: | Line 91: | ||
== References == | == References == | ||
{{reflist|2}} | |||
[[Category: Rare Disease]] | [[Category: Rare Disease]] | ||
Revision as of 13:05, 29 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Synonyms and keywords:PS
Overview
Proteus syndrome is an exceedingly rare disorder which falls under the category of hamartomatous disorder. Proteus syndrome is a very complex disorder which involves multiple organ systems in the body.
Historical Perspective
Discovery
- Proteus syndrome was first discovered by Frederick Treves, a British surgeon, in 1884.
- Frederick Treves showed the proteus syndrome on Joseph Merrick, who used to be called as the famous Elephant Man, to the Pathological Society of London.
Classification
- Proteus syndrome is one of the syndromes which falls under PTEN hamartoma tumor syndromes (PHTS). PHTS are due to germline mutations in PTEN gene.
- PTEN hamartoma tumor syndromes (PHTS) which include the following:
Pathophysiology
- Genes involved in the pathogenesis of proteus syndrome include: Mutations in the PTEN gene leads to oncogenesis
- Phosphatase and tensin homolog (PTEN) gene plays an important role in the following:
- Phosphoinositide-3-kinase (PI3K)-AKT pathway and
- Rapamycin (mTOR) signaling pathways
- PTEN track backs to 10q23 which encodes and plays a significant role in the following:
- Effects G1 cell cycle arrest and apoptosis
- Cellular proliferation and
- Migration
- Apoptosis